Meeting
2018 Gastrointestinal Cancers Symposium
Outcomes for advanced HER2-positive gastroesophageal cancer by anatomical location: Experience from the Princess Margaret Cancer Centre.
Authors
Charles Henry Lim
Princess Margaret Cancer Centre, Toronto, ON, Canada
Charles Henry Lim , Daniel Yokom , Di Maria Jiang , Lucy Xiaolu Ma , Peiran Sun , Hao-Wen Sim , Akina Natori , Bryan Anthony Chan , Stephanie Moignard , Jennifer J. Knox , Eric Xueyu Chen , Geoffrey Liu , Carol Jane Swallow , Gail Elizabeth Darling , Savtaj Singh Brar , Sara Hafezi-Bakhtiari , James Conner , Elena Elimova , Raymond Woo-Jun Jang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 131)
DOI
10.1200/JCO.2018.36.4_suppl.131
Abstract #
131
Poster Bd #
J12
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Final results of a phase II trial of first-line FOLFIRINOX for advanced gastroesophageal cancers.
First Author: Ramon Jin
Poster
2015 ASCO Annual Meeting
Impact of systemic therapy on the outcomes of patients with metastatic breast cancer to brain: MD Anderson Cancer Center (MDACC) experience 1999-2012.
First Author: Diogo Bugano Diniz Gomes
Poster
2015 Gastrointestinal Cancers Symposium
A phase II trial of 5-weekly S-1 plus cisplatin (CDDP) combination with trastuzumab (Tmab) for HER2-positive advanced gastric or esophagogastric junction (EGJ) cancer: WJOG7212G (T-SPACE) study.
First Author: Yuji Miura
Poster
2022 ASCO Annual Meeting
Comparison of four clinical prognostic scores in patients with advanced gastric and esophageal cancer.
First Author: Lucy Xiaolu Ma